Trial Profile
Randomized, Double-blind, Placebo Controlled, Crossover Clinical Study to Analyse the Effect of Empagliflozin on Macrovascular and Microvascular Circulation and on Endothelium Function
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 18 Oct 2018
Price :
$35
*
At a glance
- Drugs Empagliflozin (Primary)
- Indications Type 2 diabetes mellitus; Vascular disorders
- Focus Therapeutic Use
- 05 Oct 2018 Results presented at the 54th Annual Meeting of the European Association for the Study of Diabetes
- 15 Sep 2017 Results presented at the 53rd Annual Meeting of the European Association for the Study of Diabetes.
- 13 Jun 2017 Results presented at the 77th Annual Scientific Sessions of the American Diabetes Association.